Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
Bibiana Bielekova, Bonnie L. Goodwin(National Institute of Neurological Disorders and Stroke), Nancy Richert(National Institutes of Health Clinical Center), Irene Cortese(National Institute of Neurological Disorders and Stroke), Takayuki Kondo(National Institute of Neurological Disorders and Stroke), Ghazaleh Afshar(National Institute of Neurological Disorders and Stroke), Bruno Gran(National Institute of Neurological Disorders and Stroke), J.K. Eaton(National Institute of Neurological Disorders and Stroke), Jack P. Antel(Montreal Neurological Institute and Hospital), Joseph A. Frank(National Institutes of Health Clinical Center), Henry F. McFarland(National Institute of Neurological Disorders and Stroke), Roland Martinꝉ(National Institute of Neurological Disorders and Stroke)
Cited by 825
Abstract
Related Papers
No related papers found
Powered by citation graph analysis